Canada Life’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $28K | Sell |
23,606
-813
| -3% | -$990 | ﹤0.01% | 1812 |
|
|
2025
Q4 | $24K | Sell |
24,419
-5,255
| -18% | -$6.31K | ﹤0.01% | 1846 |
|
|
2025
Q3 | $30K | Buy |
29,674
+6,878
| +30% | +$7.42K | ﹤0.01% | 1846 |
|
|
2025
Q2 | $26K | Buy |
22,796
+2,395
| +12% | +$2.78K | ﹤0.01% | 1881 |
|
|
2025
Q1 | $16K | Sell |
20,401
-866
| -4% | -$1.06K | ﹤0.01% | 1958 |
|
|
2024
Q4 | $35K | Sell |
21,267
-24,365
| -53% | -$61.4K | ﹤0.01% | 1913 |
|
|
2024
Q3 | $160K | Buy |
45,632
+3,466
| +8% | +$13.5K | ﹤0.01% | 1801 |
|
|
2024
Q2 | $138K | Buy |
42,166
+30,926
| +275% | +$135K | ﹤0.01% | 1842 |
|
|
2024
Q1 | $82K | Buy |
11,240
+1,640
| +17% | +$10.2K | ﹤0.01% | 1964 |
|
|
2023
Q4 | $36K | Sell |
9,600
-676
| -7% | -$1.6K | ﹤0.01% | 2064 |
|
|
2023
Q3 | $22K | Hold |
10,276
| – | – | ﹤0.01% | 2113 |
|
|
2023
Q2 | $49K | Buy |
10,276
+5,791
| +129% | +$32K | ﹤0.01% | 2008 |
|
|
2023
Q1 | $26K | Buy |
4,485
+286
| +7% | +$1.73K | ﹤0.01% | 2165 |
|
|
2022
Q4 | $42K | Buy |
4,199
+167
| +4% | +$3.14K | ﹤0.01% | 2105 |
|
|
2022
Q3 | $91K | Buy |
4,032
+67
| +2% | +$1.94K | ﹤0.01% | 2002 |
|
|
2022
Q2 | $99K | Buy |
3,965
+63
| +2% | +$1.74K | ﹤0.01% | 1917 |
|
|
2022
Q1 | $161K | Sell |
3,902
-497
| -11% | -$19.2K | ﹤0.01% | 1913 |
|
|
2021
Q4 | $257K | Buy |
4,399
+60
| +1% | +$3.4K | ﹤0.01% | 1829 |
|
|
2021
Q3 | $259K | Hold |
4,339
| – | – | ﹤0.01% | 1861 |
|
|
2021
Q2 | $376K | Sell |
4,339
-14
| -0.3% | -$1.13K | ﹤0.01% | 1797 |
|
|
2021
Q1 | $356K | Buy |
4,353
+56
| +1% | +$5.37K | ﹤0.01% | 1820 |
|
|
2020
Q4 | $389K | Hold |
4,297
| – | – | ﹤0.01% | 1814 |
|
|
2020
Q3 | $172K | Hold |
4,297
| – | – | ﹤0.01% | 1931 |
|
|
2020
Q2 | $147K | Hold |
4,297
| – | – | ﹤0.01% | 1962 |
|
|
2020
Q1 | $96K | Hold |
4,297
| – | – | ﹤0.01% | 1986 |
|
|
2019
Q4 | $83K | Buy |
+4,297
| New | +$68.2K | ﹤0.01% | 2117 |
|
|
2019
Q3 | – | Sell |
-8,003
| Closed | -$162K | – | 1496 |
|
|
2019
Q2 | $162K | Hold |
8,003
| – | – | ﹤0.01% | 2083 |
|
|
2019
Q1 | $140K | Hold |
8,003
| – | – | ﹤0.01% | 1964 |
|
|
2018
Q4 | $99K | Hold |
8,003
| – | – | ﹤0.01% | 2154 |
|
|
2018
Q3 | $130K | Hold |
8,003
| – | – | ﹤0.01% | 2108 |
|
|
2018
Q2 | $91K | Buy |
+8,003
| New | +$88.2K | ﹤0.01% | 2219 |
|
Other funds holding FATE
RG
VCM
VPM
JJ
Canada Life's FATE Position: Q1 2026 in Review
Canada Life reduced its Fate Therapeutics (FATE) stake by 3.3% in Q1 2026, selling an estimated $990 and leaving 23,606 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #1812.
Canada Life first reported a position in FATE in Q2 2018 and has held it in 31 quarters since. The position peaked at $389K in Q4 2020. 157 funds tracked by Wall St. Rank hold FATE as of Q1 2026.
- Canada Life held 23,606 shares of Fate Therapeutics worth $28K as of Q1 2026.
- Canada Life sold 813 Fate Therapeutics shares in Q1 2026, an estimated $990.
- Fate Therapeutics made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1812 holding.
- Canada Life first reported a position in Fate Therapeutics in Q2 2018 and has held it in 31 quarters since.
- Canada Life's Fate Therapeutics position peaked at $389K in Q4 2020.
- 157 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.